Inside MedSpa — Never miss a recall or a rule change.
Today's Medspa Watch — Nov 8, 2026
Get the free Inside MedSpa brief by email
The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.
Business & M&A
Evolus posts Q3 loss of $0.09, revenue tops estimates
Regulatory
Judge bars Medicare price for Botox over plasma rule
Business & M&A
Hugel Signs Half of Target U.S. Accounts Post-Switch
Business & M&A
Maple Grove med spa adds PA-led hormone and weight program
Business & M&A
Sofwave Q3 revenue up 35% to $28.5M; China nod
Why this exists
They're not smarter than you. They just read the filings.
Every week the FDA clears a device, a state board rewrites who can inject what, a manufacturer quietly changes its pricing. None of it is secret — the clearances, the enforcement actions, the rule changes are all published, all public, and buried in databases no practice owner has time to check. Device reps and consultants have staff for that. Now you have us.
How Inside MedSpa works →Latest Across the Industry
All coverage →-
Business & M&A
Evolus Q3 revenue up 13%, fourth straight positive EBITDA quarter
Evolus says toxin and hyaluronic acid sales both grew in the third quarter, and it is reaffirming 2026 guidance while it adds a Profhilo partnership and a hair-growth option.
-
Business & M&A
Sofwave names Optimedic main distributor in Spain
The ultrasound maker picks a Spanish distributor to reach more clinics, and the document leaves its regulatory details and terms unstated.
-
Business & M&A
Galderma nine-month sales hit $4.77B, guidance raised
Galderma reported record first-nine-month 2026 net sales of 4,765 million USD, lifted its full-year growth guidance, and tied the lift to a $1.5 billion ZO Skin Health purchase.
-
Regulatory
FDA clears AMIRO LED wrinkle mask under 510(k)
Shenzhen Accompany Technology's over-the-counter light mask was found substantially equivalent to a predicate, and the FDA listing says little more.
-
Business & M&A
AbbVie director Jennifer Davis resigns to lead Align
AbbVie's board loses Jennifer L. Davis, a Class II director, effective November 2, 2026, after she took the CEO job at Align Technology.
-
Market
Revance survey: 74% say menopause raised aesthetic interest
A company-sponsored survey of 1,279 women links perimenopause to more demand for aesthetic care and for providers who understand hormonal aging.
-
Market
BOTOX Cosmetic Day returns Nov. 18 with Allē offers
Allergan Aesthetics sets its eighth BOTOX Cosmetic Day for Wednesday, Nov. 18, pairing a BOGO gift card offer with a November refer-a-friend credit.
-
Regulatory
Inibio's Inibo wins China approval, third Korean toxin
China's NMPA has approved Inibio's type-A botulinum toxin, with commercial launch targeted for Q1 2027.
-
Business & M&A
AbbVie's Aesthetics Revenue Slips as Botox Cosmetic Gains
Allergan Aesthetics posted a 1.8 percent operational decline in Q3 2026, with Botox Cosmetic up 4.1 percent but Juvederm down 11.8 percent.
Why owners trust it
See exactly how we source & verify →
Primary sources. No agenda. Verified before it runs.
Straight from the recordFDA, SEC EDGAR, the Federal Register, and state boards — read directly, not rehashed from blogs.
Independent by designWe sell no devices, software, or financing — so the take answers to you, never an advertiser.
AI speed, verified factsA purpose-built engine reads everything; a verification step holds anything that doesn’t trace to a source.
Owners onlyFiltered to one test: does this touch your money, your license, or your patients’ demand?